ArticleBritish journal of cancer2019

Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer.

Chitra Joseph et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.